Arqit Quantum (ARQQ) acquires Ampliphae's technology IP
Get Alerts ARQQ Hot Sheet
Join SI Premium – FREE
Arqit Quantum Inc. (Nasdaq: ARQQ) (“Arqit” or the “Company”), a global leader in quantum-safe encryption, today announced the acquisition of Ampliphae’s product portfolio IP and innovations team. The Ampliphae product portfolio and team specialises in encryption risk advisory and AI analytics.
This acquisition brings together Ampliphae’s industry-leading Encryption Intelligence products with Arqit’s quantum encryption technology and global reach, delivering a comprehensive proposition to identify and mitigate cyber risk exposure from both current and quantum threats.
Ampliphae’s core products provide organisations with complete visibility into all encryption technologies in use, automatically identifying weak points and vulnerabilities, including those susceptible to quantum attacks. The service enables customers to manage their encryption risk, address insecure practices, and develop efficient and cost-effective mitigation strategies for migrating to quantum-safe encryption.
With Arqit’s international presence, Ampliphae’s encryption risk advisory service will now be available to enterprises and governments worldwide, helping them on the journey to securing sensitive data across cloud, edge, IoT, and hybrid environments.
“Encryption Intelligence is a vital choice for organisations looking to understand and reduce their encryption risk,” said Andy Leaver, CEO of Arqit. “By combining our quantum encryption expertise with Ampliphae’s analytics technologies, we can deliver unmatched protection and advisory services on a global scale.”
Trevor Graham, CEO of Ampliphae, added: “Joining Arqit allows us to extend our mission, helping organisations identify and address both current and quantum encryption risks, to a worldwide audience. Together, we’re enabling customers to build robust, future-proof security strategies.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trinity Biotech faces Nasdaq delisting risk over market value
- Canada invests CAD $195M in Xanadu for quantum manufacturing
- Target (TGT) files mixed shelf
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share